Article ID Journal Published Year Pages File Type
8626395 Placenta 2018 6 Pages PDF
Abstract
r-TM as an anticoagulation therapy has the potential for the medical treatment of recurrent miscarriage and fetal growth restriction due to improved angiogenic factors. Additionally, r-TM treatment has the potential for the recovery of preeclampsia.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Developmental Biology
Preview
Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia
Authors
, , , , , , , , ,